1RODEN M, BERNROIDER E. Hepatic glucose metabolism in humans:its role in health and disease [ J ]. Best Pract Res Clin Endocrinol Metab, 2003, 17 ( 3 ) :365-383.
3KURUKULASURIYA R, LINK J T, MADAR D J, et al. Prospeers for pharmacologic inhibition of hepatic: glucose production [J]. CurrMedChem, 2003, 10 (2) :99-121.
4BARF T. Intervention of hepatic glucose production. Small molecule regulators of potential targets for type 2 d ahetes therapy [ J ]. Mini Rer Med Chem, 2004, 4 (8) :897-908.
5HENKE B R, SPARKS S M. Glycogen phosphorylase inhibitors [J] . Mini Rev Med Chem, 2006, 6 (8) :845-857.
6BAKER D J, GREENHAFF P L, TIMMONS J A. C-lyeogen phosphorylase inhibition a.s a therapeutie target :a review of the recent patent literature[J]. Expert Opin Ther Pot, 2006, 16 (4) :459-466.
7FOSGERAU K, WESTERGAARD N, QUISTORFF B, et al. Kinetic and functional characterization of 1,4-dideoxy-1 ,4-imino-D- arabinitol:a potent inhibitor of glycogen phosphorylase with anti- hyperglyceamic effect in ob/ob mice[ J ]. Arch Biochem Biophys, 2000, 380 (2):274-284.
8OIKONOMAOS N G, SCHNIER J B, ZOGRAPHOS S E, et al. Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site[J]. J Biol Chem, 2000, 275 (44) :34566-34573.
9ZOGRAPHOS S E, OIKONOMAOS N G, TSITSANOU K E, et al. The structure of glycogen phosphorylase b with an alkyl-dihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor[J]. Structure, 1997, 5 (11):1413-1425.
10CHEN J, LIU .J, ZHANG L Y, et al. PentacycLic triterpenes. Part 3 :Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphoulase[J ]. Bioorg Med Chem Lett, 2006, 16 ( 11 ) :2915-2919.
2Chandy MJ,Ravindra J. Effect of dichloracetate on infarct size in a primate model of focal cerebral ischaemia [J]. Neurol India, 2000,48; 227 - 230.
3Niwa M, Hara A, Iwai T, et al. Prevention of ischemia-induced hippocampal neuronal damage by 2-deoxy-D-glucose in gerbils[J].Life Sci, 1999,64(18) : PL193 - PL198.
4Oudard S, Poirson F, Miccoli L, et al. Mitochondria-bound hexokinase as target for therapy of malignant gliomas[J]. Intern J Cancer, 1995,62(2) :216 - 222.
5Tidmarsh G. Treatment of benign prostatic hyperplasia: PCT,W02004064735 [P]. 2005-08-05.
6Claustre S, Denier C, Lakhdar-Ghazal F, et al. Exploring the active site of trypanosoma brucei phosphofructokinase by inhibition studies:specific irreversible inhibition[J], Biochem,2002,41(32):10183 -10193.
7Guminska M, Kedryna T, Marchut E. The effect of levamisole on energy-metabolism in ehrlich ascites tumor-cells in vitro [J].Biochem Pharmacol, 1986,35(24) :4369-4374.
8Tidmarsh G. Treatment of cancer with 2-deoxyglucose: US,US2005245462 [P]. 2005-11-03.
9Lampidis T, Priebe W. Manipulation of oxidative phosphorylation for hypersensitizing tumor cells to glycolytic inhibitors: PCT, W00182926[P].2001-11-08.
10Veyhl M. Wagner K, Volk C, et al. Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard(D-19575) into tumor cells is mediated by the Na^+ -D-glucose cotransporter SAAT1[J]. Proc Natl Aatcl Sci USA, 1998,95 (6) :2914-2919.
